Search

BackgroundSubstance use (SU) contributes to poor health outcomes, yet limited data exist to inform strategies to optimize SU treatment among persons with human immunodeficiency virus (HIV). We describe SU and SU treatment utilization among women with and without HIV in the Women's Interagency HIV Study (WIHS).MethodsWe included data from women enrolled in WIHS from 2013 to 2020. Current SU was self-reported, nonmedical use of drugs in the past year, excluding use of only marijuana. SU treatment utilization was self-reported use of a drug treatment program in the past year. Multivariable regression models were used to investigate associations between participant characteristics and SU treatment.ResultsAmong 2559 women (1802 women living with HIV [WWH], 757 women without HIV), 14% reported current SU. Among those with current SU (n = 367), 71% reported crack/cocaine followed by 40% reporting opioids, and 42% reported any treatment in the past year. The most common treatments were methadone (64%), Narcotics Anonymous (29%), inpatient programs (28%), and outpatient programs (16%). Among women using opioids (n = 147), 67% reported methadone use in the past year compared to 5% using buprenorphine/naloxone. Multivariable analysis showed lower odds of treatment utilization among WWH with concurrent alcohol or marijuana use. Visiting a psychiatrist/counselor was associated with higher odds of treatment. Among WWH, SU treatment was not associated with HIV-related clinical outcomes.ConclusionsTreatment utilization was high, especially for methadone use. Our results highlight opportunities for accessing SU treatment for WWH, such as the need to prioritize buprenorphine and comprehensive, wraparound services in HIV care settings.

Specific energy prediction is critically important to enhance field performance of agricultural implements. It enables optimal utilization of tractor power, reduced inefficiencies, and identification of comprehensive inputs for designing energy-efficient implements. In this study, A 3-5-1 artificial neural network (ANN) model was developed to estimate specific energy requirement of a vertical axis rotor type intra-row weeding tool. The depth of operation in soil bed, soil cone index, and forward/implement speed ratio (u/v) were selected as the input variables. Soil bin investigations were conducted using the vertical axis rotor (RVA), interfaced with draft, torque, speed sensors, and data acquisition system to record dynamic forces employed during soil–tool interaction at ranges of different operating parameters. The depth of operation (DO) had the maximum influence on the specific energy requirement of the RVA, followed by the cone index (CI) and the u/v ratio. The developed ANN model was able to predict the specific energy requirements of RVA at high accuracies as indicated by high R2 (0.91), low RMSE (0.0197) and low MAE (0.0479). Findings highlight the potential of the ANN as an efficient technique for modeling soil–tool interactions under specific experimental conditions. Such estimations will eventually optimize and enhance the performance efficiency of agricultural implements in the field.

AIM: To characterize the association between diabetes and transfusion and clinical outcomes in cardiac surgery, and to evaluate whether restrictive transfusion thresholds are harmful in these patients. MATERIALS AND METHODS: The multinational, open-label, randomized controlled TRICS-III trial assessed a restrictive transfusion strategy (haemoglobin [Hb] transfusion threshold <75 g/L) compared with a liberal strategy (Hb <95 g/L for operating room or intensive care unit; or <85 g/L for ward) in patients undergoing cardiac surgery on cardiopulmonary bypass with a moderate-to-high risk of death (EuroSCORE ≥6). Diabetes status was collected preoperatively. The primary composite outcome was all-cause death, stroke, myocardial infarction, and new-onset renal failure requiring dialysis at 6 months. Secondary outcomes included components of the composite outcome at 6 months, and transfusion and clinical outcomes at 28 days. RESULTS: Of the 5092 patients analysed, 1396 (27.4%) had diabetes (restrictive, n = 679; liberal, n = 717). Patients with diabetes had more cardiovascular disease than patients without diabetes. Neither the presence of diabetes (OR [95% CI] 1.10 [0.93-1.31]) nor the restrictive strategy increased the risk for the primary composite outcome (diabetes OR [95% CI] 1.04 [0.68-1.59] vs. no diabetes OR 1.02 [0.85-1.22]; Pinteraction = .92). In patients with versus without diabetes, a restrictive transfusion strategy was more effective at reducing red blood cell transfusion (diabetes OR [95% CI] 0.28 [0.21-0.36]; no diabetes OR [95% CI] 0.40 [0.35-0.47]; Pinteraction = .04). CONCLUSIONS: The presence of diabetes did not modify the effect of a restrictive transfusion strategy on the primary composite outcome, but improved its efficacy on red cell transfusion. Restrictive transfusion triggers are safe and effective in patients with diabetes undergoing cardiac surgery.

Drugs that inhibit the sodium–glucose co-transporter 2 (SGLT2) have been shown to reduce the risk of hospitalizations for heart failure in patients with type 2 diabetes. In populations that largely did not have heart failure at the time of enrolment, empagliflozin, canagliflozin and dapagliflozin decreased the risk of serious new-onset heart failure events by ≈30%. In addition, in the EMPA-REG OUTCOME trial, empagliflozin reduced the risk of both pump failure and sudden deaths, the two most common modes of death among patients with heart failure. In none of the three trials could the benefits of SGLT2 inhibitors on heart failure be explained by the actions of these drugs as diuretics or anti-hyperglycaemic agents. These observations raise the possibility that SGLT2 inhibitors could reduce morbidity and mortality in patients with established heart failure, including those without diabetes. The EMPEROR-Reduced trial is enrolling ≈3600 patients with heart failure and a reduced left ventricular ejection fraction (≤ 40%), half of whom are expected not to have diabetes. Patients are being randomized to placebo or empagliflozin 10 mg daily, which is added to all appropriate treatment with inhibitors of the renin–angiotensin system and neprilysin, beta-blockers and mineralocorticoid receptor antagonists. The primary endpoint is the time-to-first event analysis of the combined risk of cardiovascular death and hospitalization for heart failure, but the trial will also evaluate the effects of empagliflozin on renal function, cardiovascular death, all-cause mortality, and recurrent hospitalization events. By adjusting eligibility based on natriuretic peptide levels to the baseline ejection fraction, the trial will preferentially enrol high-risk patients. A large proportion of the participants is expected to have an ejection fraction < 30%, and the estimated annual event rate is expected to be at least 15%. The EMPEROR-Reduced trial is well-positioned to determine if the addi

Background: The principal biological processes that characterize heart failure with a preserved ejection fraction (HFpEF) are systemic inflammation, epicardial adipose tissue accumulation, coronary microcirculatory rarefaction, myocardial fibrosis and vascular stiffness; the resulting impairment of left ventricular and aortic distensibility (especially when accompanied by impaired glomerular function and sodium retention) causes increases in cardiac filling pressures and exertional dyspnoea despite the relative preservation of left ventricular ejection fraction. Independently of their actions on blood glucose, sodium–glucose co-transporter 2 (SGLT2) inhibitors exert a broad range of biological effects (including actions to inhibit cardiac inflammation and fibrosis, antagonize sodium retention and improve glomerular function) that can ameliorate the pathophysiological derangements in HFpEF. Such SGLT2 inhibitors exert favourable effects in experimental models of HFpEF and have been found in large-scale trials to reduce the risk for serious heart failure events in patients with type 2 diabetes, many of whom were retrospectively identified as having HFpEF. Study design: The EMPEROR-Preserved Trial is enrolling ≈5750 patients with HFpEF (ejection fraction >40%), with and without type 2 diabetes, who are randomized to receive placebo or empagliflozin 10 mg/day, which is added to all appropriate treatments for HFpEF and co-morbidities. Study aims: The primary endpoint is the time-to-first-event analysis of the combined risk for cardiovascular death or hospitalization for heart failure. The trial will also evaluate the effects of empagliflozin on renal function, cardiovascular death,. all-cause mortality and recurrent hospitalization events, and will assess a wide range of biomarkers that reflect important pathophysiological mechanisms that may drive the evolution of HFpEF. The EMPEROR-Preserved Trial is well positioned to determine if empagliflozin can have a meaningfu

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

BackgroundIntegrase strand transfer inhibitors (INSTIs) have been associated with weight gain among women living with HIV. We aimed to investigate the association between INSTIs and change in cardiometabolic risk indicators.SettingRetrospective cohort.MethodsData from 2006 to 2017 were analyzed from women living with HIV enrolled in the longitudinal Women's Interagency HIV Study who were virally controlled on antiretroviral therapy (ART) for ≥5 consecutive semiannual visits. Women who switched/added an INSTI to ART (INSTI group) were compared with women who remained on non-INSTI ART (non-INSTI group). Outcomes included changes in fasting lipids and glucose, hemoglobin A1c (HbA1c), blood pressure (BP), and incident diabetes, hypertension, and insulin resistance. Outcomes were measured 6-12 months before and 6-18 months after INSTI switch/add in the INSTI group with comparable visits in the non-INSTI group. Longitudinal linear regression models compared change over time in each outcome by the study group.ResultsOne thousand one hundred eighteen participants (234 INSTI, 884 non-INSTI) were followed for a median 2.0 (Q1 1.9, Q3 2.0) years. Participants were median age 49 years, 61% Black, and 73% overweight or obese (body mass index ≥25 kg/m). Compared with non-INSTI, the INSTI group experienced greater increases in HbA1c (+0.05 vs. -0.06 mg/dL, P = 0.0318), systolic BP (+3.84 vs. +0.84 mm Hg, P = 0.0191), and diastolic BP (+1.62 vs. -0.14 mm Hg, P = 0.0121), with greatest change in HbA1c among women on INSTIs with ≥5% weight gain.ConclusionsINSTI use was associated with unfavorable changes in HbA1c and systolic and diastolic BP during short-term follow-up. Further research is needed to understand long-term cardiometabolic effects of INSTI use.

BackgroundIntegrase strand-transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is recommended for human immunodeficiency virus (HIV) management. Although studies have suggested associations between INSTIs and weight gain, women living with HIV (WLHIV) have been underrepresented in research. We evaluated the effect of switching or adding INSTIs among WLHIV.MethodsWomen enrolled in the Women's Interagency HIV Study (WIHS) from 2006-2017 who switched to or added an INSTI to ART (SWAD group) were compared to women on non-INSTI ART (STAY group). Body weight, body mass index (BMI), percentage body fat (PBF), and waist, hip, arm, and thigh circumferences were measured 6-12 months before and 6-18 months after the INSTI switch/add in SWAD participants, with comparable measurement time points in STAY participants. Linear regression models compared changes over time by SWAD/STAY group, adjusted for age, race, WIHS site, education, income, smoking status, and baseline ART regimen.ResultsWe followed 1118 women (234 SWAD and 884 STAY) for a mean of 2.0 years (+/- 0.1 standard deviation [SD]; mean age 48.8 years, SD +/- 8.8); 61% were Black. On average, compared to the STAY group, the SWAD group experienced mean greater increases of 2.1 kg in body weight, 0.8 kg/m2 in BMI, 1.4% in PBF, and 2.0, 1.9, 0.6, and 1.0 cm in waist, hip, arm, and thigh circumference, respectively (all P values < .05). No differences in magnitudes of these changes were observed by INSTI type.ConclusionsIn WLHIV, a switch to INSTI was associated with significant increases in body weight, body circumferences, and fat percentages, compared to non-INSTI ART. The metabolic and other health effects of these changes deserve further investigation.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

This study sought to identify whether piggery effluent-derived nitrogen sources can be formulated with urea and nitrification inhibitors to better synchronize nitrogen (N) supply with crop demand than conventional urea fertilizer alone. A 288 pot pasture growth and leaching growth accelerator trial (5 pasture cuts) was completed with a factorial treatment structure of three N sources (2.63 g N [kg soil]?1 applied as 100% urea-N, 8% struvite-N + 92% urea-N, and 8% piggery pond sludge-N + 92% urea-N), five rates of three nitrification inhibitors (including 3,4-Dimethylpyrazole phosphate, DMPP; limonene+ethanol; and dicyandiamide, DCD), and matrix encapsulated forms of these inhibitors. Applying a combination of piggery sludge with urea increased N uptake during the first 4 weeks of plant growth (by 65%), though total N uptake throughout the trial (22 weeks) did not differ across the N-sources. The microbial community of the soil to which the sludge was added was significantly different from the un-amended soil at the conclusion of the trial. All inhibitor formulations significantly decreased leaching losses of mineral-N relative to the control (by 14 to 61%). The use of DMPP decreased initial nutrient uptake, deferring uptake until later in the experiment. Inhibitor addition resulted in microbial community effects that persisted throughout the trial. The study demonstrated that a piggery-derived N-source and a nitrification inhibitor can be used to manipulate plant N uptake to occur later or earlier in a growing period with equal cumulative uptake, achieving an 11% increase in residual N store, and decreased N leaching losses.

Background: The Pneumatic CompREssion for Preventing VENous Thromboembolism (PREVENT) trial evaluates the effect of adjunctive intermittent pneumatic compression (IPC) with pharmacologic thromboprophylaxis compared to pharmacologic thromboprophylaxis alone on venous thromboembolism (VTE) in critically ill adults. Methods/design: In this multicenter randomized trial, critically ill patients receiving pharmacologic thromboprophylaxis will be randomized to an IPC or a no IPC (control) group. The primary outcome is "incident" proximal lower-extremity deep vein thrombosis (DVT) within 28 days after randomization. Radiologists interpreting the lower-extremity ultrasonography will be blinded to intervention allocation, whereas the patients and treating team will be unblinded. The trial has 80% power to detect a 3% absolute risk reduction in the rate of proximal DVT from 7% to 4%. Discussion: Consistent with international guidelines, we have developed a detailed plan to guide the analysis of the PREVENT trial. This plan specifies the statistical methods for the evaluation of primary and secondary outcomes, and defines covariates for adjusted analyses a priori. Application of this statistical analysis plan to the PREVENT trial will facilitate unbiased analyses of clinical data.

We propose an “efficacy-to-effectiveness” (E2E) clinical trial design, in which an effectiveness trial would commence seamlessly upon completion of the efficacy trial. Efficacy trials use inclusion/exclusion criteria to produce relatively homogeneous samples of participants with the target condition, conducted in settings that foster adherence to rigorous clinical protocols. Effectiveness trials use inclusion/exclusion criteria that generate heterogeneous samples that are more similar to the general patient spectrum, conducted in more varied settings, with protocols that approximate typical clinical care. In E2E trials, results from the efficacy trial component would be used to design the effectiveness trial component, to confirm and/or discern associations between clinical characteristics and treatment effects in typical care, and potentially to test new hypotheses. An E2E approach may improve the evidentiary basis for selecting treatments, expand understanding of the effectiveness of treatments in subgroups with particular clinical features, and foster incorporation of effectiveness information into regulatory processes., National Center for Research Resources (U.S.) (Grant UL1 RR025752), National Center for Advancing Translational Sciences (U.S.) (Grant UL1 TR000073)

Langerhans cell histiocytosis (LCH) accounts for less than 1% of all orbital tumours. Though rare, orbital involvement in LCH is not uncommon. Most reports so far have been in Western literature. We report here a case of LCH of orbit with intracranial extension. To the best of our knowledge, this is the first case of single system multifocal LCH reported from India.

The problem of testing a dose-response relationship in the presence of exchangeably correlated binary data has been addressed using a variety of models. Most commonly used approaches are derived from likelihood or generalized estimating equations and rely on large-sample theory to justify their inferences. However, while earlier work has determined that these methods may perform poorly for small or sparse samples, there are few alternatives available to those faced with such data. We propose an exact trend test for exchangeably correlated binary data when groups of correlated observations are ordered. This exact approach is based on an exponential model derived by Molenberghs and Ryan (1999) and Ryan and Molenberghs (1999) and provides natural analogues to Fisher's exact test and the binomial trend test when the data are correlated. We use a graphical method with which one can efficiently compute the exact tail distribution and apply the test to two examples.

The problem of testing a dose-response relationship in the presence of exchangeably correlated binary data has been addressed using a variety of models. Most commonly used approaches are derived from likelihood or generalized estimating equations and rely on large-sample theory to justify their inferences. However, while earlier work has determined that these methods may perform poorly for small or sparse samples, there are few alternatives available to those faced with such data. We propose an exact trend test for exchangeably correlated binary data when groups of correlated observations are ordered. This exact approach is based on an exponential model derived by Molenberghs and Ryan (1999) and Ryan and Molenberghs (1999) and provides natural analogues to Fisher's exact test and the binomial trend test when the data are correlated. We use a graphical method with which one can efficiently compute the exact tail distribution and apply the test to two examples.

Pub. in Il Nuovo Cimento v36 (Ser10) p202-5 1965 (Copies available only to DDC users).

© 2016 Taylor and Francis Group, LLC. The present study aimed to investigate microbial communities in seven Indian composts and their potential for biocontrol of Fusarium oxysporum f. sp. lycopersici. In addition, identification of bioactive substances in disease suppressive composts was also attempted. Composts were chosen based on disease suppressiveness and subjected to molecular microbial analyses. Total genomic DNA from the composts was extracted and amplified with polymerase chain reaction using primers targeting the 18S rRNA and 16S rRNA genes of fungi and bacteria, respectively. Denaturing gradient gel electrophoresis (DGGE) fingerprinting and DNA sequencing were used to identify the fungal and bacterial targets. Phylogenetic analysis of the fungal 18S rRNA ITS gene sequences showed that phylum Ascomycota was dominant in all composts, while in the bacterial 16S rRNA gene sequences, the phylum Proteobacteria was dominant. Some fungi in disease suppressive composts grouped phylogenetically close to F. oxysporum. Bacterial sequences with close similarity (>95% identity) with Actinobacterium showed a strong presence only in disease suppressive composts. Disease suppressive composts formed a separate group in the cluster analysis of 18S rRNA ITS and 16S rRNA gene sequences. Gas chromatography-time of flight-mass spectrometry was performed with compost extracts to determine if bioactive substances were present in disease suppressive composts. The analysis of compost organic matter showed a negative association of disease suppressiveness with phloroglucinol, sitosterol, and monoenoic fatty acid, while cholesterol and certain organic acids were positively associated with suppressiveness.

© 2016 Taylor and Francis Group, LLC. The present study aimed to investigate microbial communities in seven Indian composts and their potential for biocontrol of Fusarium oxysporum f. sp. lycopersici. In addition, identification of bioactive substances in disease suppressive composts was also attempted. Composts were chosen based on disease suppressiveness and subjected to molecular microbial analyses. Total genomic DNA from the composts was extracted and amplified with polymerase chain reaction using primers targeting the 18S rRNA and 16S rRNA genes of fungi and bacteria, respectively. Denaturing gradient gel electrophoresis (DGGE) fingerprinting and DNA sequencing were used to identify the fungal and bacterial targets. Phylogenetic analysis of the fungal 18S rRNA ITS gene sequences showed that phylum Ascomycota was dominant in all composts, while in the bacterial 16S rRNA gene sequences, the phylum Proteobacteria was dominant. Some fungi in disease suppressive composts grouped phylogenetically close to F. oxysporum. Bacterial sequences with close similarity (>95% identity) with Actinobacterium showed a strong presence only in disease suppressive composts. Disease suppressive composts formed a separate group in the cluster analysis of 18S rRNA ITS and 16S rRNA gene sequences. Gas chromatography-time of flight-mass spectrometry was performed with compost extracts to determine if bioactive substances were present in disease suppressive composts. The analysis of compost organic matter showed a negative association of disease suppressiveness with phloroglucinol, sitosterol, and monoenoic fatty acid, while cholesterol and certain organic acids were positively associated with suppressiveness.